Cempra has two antibiotic candidates, solithromycin (CEM-101) and TAKSTA™ (CEM-102, sodium fusidate), in clinical trials. Both target the growing problem of antimicrobial resistance.
Solithromycin is a next-generation macrolide, the first fluorok...查看全文
$Cempra, Inc.(CEMP)$ 8-K - Current report Filed: 2017-08-09 AccNo: 0001193125-17-252119 Size: 112 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cempra, Inc.(CEMP)$ 美东时间 2017-08-09 盘前 披露财报,预期EPS -0.32 网页链接
$Cempra, Inc.(CEMP)$ 8-K - Current report Filed: 2017-06-28 AccNo: 0001193125-17-216478 Size: 135 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial...
$Cempra(CEMP)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-06-13 AccNo: 0001214659-17-003968 Size: 71 KB 网页链接
$Cempra(CEMP)$ EFFECT - Notice of Effectiveness Filed: 2017-05-01 AccNo: 9999999995-17-001095 Size: 1 KB 网页链接
$Cempra(CEMP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-04-28 AccNo: 0001564590-17-007657 Size: 4 MB 网页链接
$Cempra(CEMP)$ POS AM - Post-Effective amendments for registration statement Filed: 2017-04-28 AccNo: 0001193125-17-145253 Size: 238 KB 网页链接
$Cempra(CEMP)$ 8-K - Current report Filed: 2017-04-28 AccNo: 0001193125-17-145211 Size: 11 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Cempra(CEMP)$ 8-K - Current report Filed: 2017-04-28 AccNo: 0001193125-17-145207 Size: 75 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cempra(CEMP)$ 美东时间 2017-04-28 盘前 披露财报,预期EPS -0.52 网页链接